Epimune’s goal is to revolutionize diagnosis and monitoring of patients with disorders of the immune system.
Using epigenetics, Epimune develops & commercializes molecular diagnostic tests for immune cell quantification from a drop of blood in multiple immune-related disorders.
Company’s Keywords:
epigenetics, molecular diagnostics, immune cell profiling, immunodeficiency, cancer, autoimmunity
<9
<
<2017